The contribution of inflammatory process in pathogenesis and natural history of atrial fibrillation;Udział stanu zapalnego w patogenezie i historii naturalnej migotania przedsionków

Polski Merkuriusz Lekarski

Volumn 18, Issue 104, 2005, Pages 227-228

  Zyśko, Dorota ^a   Gajek, Jacek ^a   Mazurek, Walentyna ^a  

^a Wroclaw Medical University Katedra i Klinika Kardiologii   (Poland)

Author keywords

Atrial fibrillation; C reactive protein

Indexed keywords

ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN;

ANATOMY; CARDIOVASCULAR DISEASE; CARDIOVERSION; ELECTROCARDIOGRAM; FOLLOW UP; HEART ATRIUM; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HEART SURGERY; HUMAN; INFLAMMATION; MEASUREMENT; PAROXYSMAL HEART ATRIUM FIBRILLATION; PATHOGENESIS; REVIEW; RISK FACTOR; THROMBOEMBOLISM;

ACUTE-PHASE REACTION; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ELECTRIC COUNTERSHOCK; HEART ATRIA; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; PROGNOSIS; RECURRENCE; RISK FACTORS;

EID: 14644410362     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Aviles R.J. i wsp.: Inflammation as a risk factor for atrial fibrillation. Circulation, 2003, 108, 3006-3010.
2. Bruins P. i wsp.: Activation of the complement system during and after pulmonary bypass surgery: post surgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation, 1997, 96, 3542-3548.
3. Cernak J. i wsp.: C-reactive protein induces human peripheral blood monocytes to synthesise tissue factor. Blood, 1993, 82, 513-520.
4. Chunk M.K. i wsp.: C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001, 104, 2886-2891.
5. Danesh J. i wsp.: Risk factors for coronary heart disease and acute-phase proteins. Eur. Heart J., 1999, 20, 954-959.
6. Dernellis J., Panaretou M.: C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol., 2001, 56, 375-380.
7. Frustaci A. i wsp.: Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation, 1997, 96, 1180-1184.
8. Fuster V. i wsp.: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur. Heart J., 2001, 22, 1852-1923.
9. Korantzopoulos P. i wsp.: Atrial fibrillation and electrical remodelling: the potential role of inflammation and oxidative stress. Med. Sci. Monit., 2003, 9, RA225-229.
10. Lagrand W.K. i wsp.: C-reactive protein as a cardiovascular risk factor. Circulation, 1999, 100, 96-102.
11. Pepys M.B., Hirschfield G.M.: C-reactive protein: a critical update. J. Clin. Invest., 2003, 111, 1805-1812.